2022
DOI: 10.1007/978-1-0716-1920-9_9
|View full text |Cite
|
Sign up to set email alerts
|

PET Imaging of Estrogen Receptors Using 18F-Based Radioligands

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 91 publications
0
4
0
Order By: Relevance
“…Another promising avenue for further research might be assessment of 18F-fuoro-17β-estradiol and 18F-fuoro-5α-dihydrotestosterone given the impact of sex hormones on cardiovascular health 75,76 …”
Section: Future Directionsmentioning
confidence: 99%
See 1 more Smart Citation
“…Another promising avenue for further research might be assessment of 18F-fuoro-17β-estradiol and 18F-fuoro-5α-dihydrotestosterone given the impact of sex hormones on cardiovascular health 75,76 …”
Section: Future Directionsmentioning
confidence: 99%
“…Another promising avenue for further research might be assessment of 18F-fuoro-17β-estradiol and 18Ffuoro-5α-dihydrotestosterone given the impact of sex hormones on cardiovascular health. 75,76 In conclusion, ischemic heart disease is a leading cause of morbidity and mortality for women around the world. There are sex-specific differences in the pathophysiology of CAD development in women, which necessitates sex-specific diagnostic workup (Fig.…”
Section: Future Directionsmentioning
confidence: 99%
“…The last decade has witnessed the development of PET probes targeting sex hormone receptors in women with gynecological cancers, such as 18 F-fluoro-17β-estradiol and 18 F-fluoro-5α-dihydrotestosterone [ 223 , 224 ]. Given the impact of sex hormones on cardiovascular health, the use of such probes potentially constitutes an interesting research tool in the field of gender-specific medicine.…”
Section: Future Directionsmentioning
confidence: 99%
“…Thus ER imaging can potentially be used for breast cancer screening, staging, and response evaluation and for guiding therapies [ 49 , 50 ]. Many techniques have been developed to detect ligand–ER interactions, including PET [ 51 , 52 ] and fluorescence imaging [ 53 , 54 ].…”
Section: Introductionmentioning
confidence: 99%